Conference Coverage
Latest News
New Cosmeceutical as Effective as Cysteamine for Facial Melasma
The product is a "new potent melanogenesis inhibitor that exhibits a unique mode of action while preserving melanocyte integrity," said Mukta...
Latest News
These Patients May Be Less Adherent to nAMD Treatment
Patients with nAMD diagnosed by their family doctor or general practitioner had a threefold higher risk for nonadherence than those diagnosed by...
Latest News
Phase 2 Data on New Drug Class for Prurigo Nodularis Promising
At 16 weeks, all povorcitinib doses were superior to placebo in achieving at least a 4-point reduction on the Itch Numerical Rating Scale and the...
Latest News
Over 3 Years, Atopic Dermatitis Well-Controlled with Lebrikizumab
“Over the whole follow-up, 90% had no need for topical corticosteroids or any other rescue therapy,” reported Diamant Thaçi, MD, PhD.
Latest News
Topical JAK Inhibitor Shows Benefits in Small Frontal Fibrosing Alopecia Study
The slow progress to identify treatments for FFA is illustrated by the fact that only one other double-blind and randomized trial has ever been...
Latest News
Hidradenitis Suppurativa: Nodules Respond to As Needed Topical JAK Inhibitor
Entry criteria for the study included Hurley stage I or II HS with no draining tunnels. Hurley stage III patients were not eligible.
Conference Coverage
Exocrine Pancreatic Insufficiency: Optimal PERT Dose Varies by Primary Pancreatic Disease
Successful PERT is defined as the resolution of nutritional deficiencies and relief of symptoms and signs associated with insufficiency.
Conference Coverage
Genetic Marker Tied to Severe Ulcerative Colitis Identified
Time-to-event analysis showed that the association between carriers and disease severity extended beyond 3 years after diagnosis.
Latest News
Postoperative Chronic Pain: Experts Urge Better Recognition
It is important to mobilize general practitioners to “detect patients sliding toward opioid overconsumption” and refer them to the appropriate...
Latest News
Obesity Therapies: What Will the Future Bring?
“I believe that obesity won’t be cured in the future, but we will have increasingly better lifelong management with a multidisciplinary approach...
Conference Coverage
Type 2 Diabetes: Insulin-Free for 24 Months After Novel Endoscopic Procedure
At the 24-month follow-up, 11 patients were still insulin-free while maintaining A1c levels below 7.5%.